2,911 results on '"Influenza Vaccination"'
Search Results
2. Incentives for Influenza Vaccination
- Author
-
J-PAL North America and Mireille Jacobson, Associate Professor
- Published
- 2024
3. Influenza Vaccination, ACEI and ARB in the Evolution of SARS-CoV2 Infection
- Author
-
Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina, Institut Català de la Salut, and Anna Puigdellívol-Sánchez, M.D., Ph.D.
- Published
- 2024
4. Influenza vaccine during pregnancy, recommendations from healthcare providers, and race/ethnicity in the United States.
- Author
-
Xie, Shuai, Monteiro, Karine, and Gjelsvik, Annie
- Subjects
- *
MEDICAL personnel , *VACCINATION status , *INFLUENZA vaccines , *HEALTH equity , *PRENATAL care - Abstract
Objectives: We examined racial/ethnic differences in the association between influenza vaccine recommendations from healthcare providers and maternal vaccination uptake. Methods: This cross-sectional study examined data from the Pregnancy Risk Assessment Monitoring System. We categorized respondents as non-Hispanic (NH) Whites, NH-Blacks, NH-Asians, American Indians/Alaska Natives, NH Other non-Whites, and Hispanics. We conducted multivariable logistical regression models to evaluate adjusted odds ratios (AOR) and 95% confidence intervals (CI). Covariates included maternal age, marital status, education, insurance status before pregnancy, the number of previous live births, the number of prenatal care visits, and smoking status during pregnancy. Results: The prevalences of receiving influenza vaccine recommendations from healthcare providers and maternal vaccine were 80.01% and 50.42%, respectively. NH-Blacks are less likely to receive provider recommendations (AOR = 0.82; 95%CI 0.77–0.87) and be vaccinated (AOR = 0.76; 95%CI 0.72−0.80) than NH-Whites. Receiving provider recommendations was significantly associated with increased maternal influenza vaccine uptake (AOR = 15.50; 95% CI 14.51–16.55). The associations were significant for all racial/ethnic groups, with the highest among NH-Asians (AOR = 22.04; 95% CI 17.88−27.16) and the lowest among NH Other non-Whites (AOR = 11.07; 95% CI 8.25−14.86). Within NH-Asians, effectiveness among Chinese was highest (AOR = 29.39; 95% CI 18.10−47.71). Conclusions: Racial/ethnic disparities in maternal influenza vaccine uptake and receiving vaccine recommendations from healthcare providers persisted. Further studies on the racial/ethnic disparities in maternal vaccination were warranted and tailored strategies are required to reduce this health disparity. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
5. Influenza Vaccination in Adults in the United States with COPD before and after the COVID-19 Pandemic (2017–2022): A Multi-Year Cross-Sectional Study.
- Author
-
Wold, Marissa and Oancea, Sanda Cristina
- Subjects
CHRONIC obstructive pulmonary disease ,PULMONARY emphysema ,SEASONAL influenza ,INFLUENZA vaccines ,CHRONIC bronchitis - Abstract
There is limited literature regarding seasonal influenza vaccination (SIV) among those with a history of chronic obstructive pulmonary disease (HCOPD) prior to the COVID-19 pandemic, and no information on the topic assessing the years following the pandemic. This cross-sectional study used the Behavioral Risk Factor Surveillance Survey (BRFSS) data from the years 2017 to 2022 (n = 822,783 adults ages 50–79 years; 50.64% males). The exposure was a HCOPD, and the outcome was SIV within the past year. Weighted and adjusted logistic regression models were conducted overall and by the significant effect modifiers: smoking status, sex, and year. Having an HCOPD significantly increases the weighted adjusted odds (WAO) of SIV when compared to not having an HCOPD overall and by smoking status, sex, and year. For 2017 through 2022, among all current, former, and never smokers with an HCOPD, the WAO of SIV were: 1.36 (1.28, 1.45), 1.35 (1.27, 1.43), and 1.18 (1.09, 1.27), respectively. Among males with an HCOPD who were current, former, and never smokers, the WAO of SIV were: 1.35 (1.23, 1.48), 1.45 (1.33, 1.58), and 1.23 (1.05, 1.44), respectively. Among females with an HCOPD who were current, former, and never smokers, the WAO of SIV were: 1.31 (1.20, 1.43), 1.24 (1.15, 1.35), and 1.13 (1.04, 1.23), respectively. Study findings suggest males had significantly greater WAO ratios of receiving SIV than females in 2020 and 2022, during and after the COVID-19 pandemic. More specifically, males with an HCOPD who were former smokers had significantly greater WAOR of receiving SIV than females in 2020 and 2022. Understanding the potential barriers to SIV receipt by smoking status and sex, especially during a pandemic, and especially for individuals impacted by an HCOPD, is essential for better health interventions in times of a national crisis such as a pandemic. Additionally, SIV receipt is low among those with an HCOPD, and efforts should be made to improve this. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
6. Influenza Vaccination Uptake and Associated Factors among Individuals with Diabetes Mellitus in Spain: A Cross-Sectional Study Using Data from the European Health Interview Survey 2020.
- Author
-
Twomey, Eric P., Herman, David, Marín-Rodríguez, José A., and Jimenez-Moleon, Jose J.
- Subjects
INFLUENZA vaccines ,VACCINATION coverage ,MEDICAL care costs ,PEOPLE with diabetes ,INTENSIVE care units - Abstract
Background: Vaccination against influenza has proven to reduce influenza-caused hospital entries, treatment times in intensive care units and hospitalisation costs for treating people with Diabetes Mellitus (DM). Despite the existing influenza vaccination recommendations for all persons with DM, in Spain, vaccination hesitancy remains substantial, and vaccination rates lag behind target. We aimed to assess predictors for influenza vaccination uptake and reasons for non-adherence among individuals with DM. Methods: Data from the 2020 European Health Interview Survey were analysed using uni- and multivariable logistic regression models, stratified by age group and including possible confounders and vaccination as an outcome. Associations with the sociodemographic profile, healthcare access and substance use were explored. Results: Our analysis included 2194 individuals with DM over the age of 15, showing an influenza vaccination rate of 53%. The findings revealed significant predictors of vaccination uptake, including age over 60 years and robust social support. Conversely, younger age, higher education levels, infrequent healthcare interactions and economic barriers emerged as significant obstacles to vaccination. Conclusions: To enhance vaccination rates, targeted public health interventions should emphasise the importance of vaccination for younger, more educated individuals with DM, those facing economic barriers and those with lower levels of social support, which could bridge the existing gap in vaccination coverage. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
7. Socio-economic inequalities in the use of flu vaccination in Europe: a multilevel approach.
- Author
-
Jemna, Dănuț-Vasile, David, Mihaela, Bonnal, Liliane, and Oros, Cornel
- Subjects
INFLUENZA vaccines ,VACCINATION ,YOUNG adults ,OLDER people ,AGE groups - Abstract
Background: The European-wide statistics show that the use of flu vaccination remains low and the differences between countries are significant, as are those between different population groups within each country. Considerable research has focused on explaining vaccination uptake in relation to socio-economic and demographic characteristics, health promotion and health behavior factors. Nevertheless, few studies have aimed to analyze between-country differences in the use of flu vaccination for the EU population. To address this gap, this study examines the socio-economic inequalities in the use of influenza vaccination for the population aged 15 years and over in all 27 EU Member States and two other non-EU countries (Iceland and Norway). Methods: Using data from the third wave of European Health Interview Survey (EHIS) 2019, we employed a multilevel logistic model with a random intercept for country, which allows controlling simultaneously the variations in individuals' characteristics and macro-contextual factors which could influence the use of flu vaccination. In addition, the analysis considers the population stratified into four age groups, namely adolescents, young adults, adults and elderly, to better capture heterogeneities in flu vaccination uptake. Results: The main findings confirm the existence of socio-economic inequalities between individuals in different age groups, but also of significant variation between European countries, particularly for older people, in the use of influenza vaccination. In this respect, income and education are strong proxy of socio-economic status associated with flu vaccination uptake. Moreover, these disparities within each population group are also explained by area of residence and occupational status. Particularly for the elderly, the differences between individuals in vaccine utilization are also explained by country-level factors, such as the type of healthcare system adopted in each country, public funding, personal health expenditure burden, or the availability of generalist practitioners. Conclusions: Overall, our findings reveal that vaccination against seasonal influenza remains a critical public health intervention and bring attention to the relevance of conceiving and implementing context-specific strategies to ensure equitable access to vaccines for all EU citizens. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
8. Understanding the mechanisms behind descriptive norms on influenza vaccination intention: the role of concerns about vaccine safety and effectiveness.
- Author
-
Lyu, Xiaokang, Yang, Tingting, Wang, Yi, and Fu, Chunye
- Subjects
FLU vaccine efficacy ,PUBLIC health officers ,VACCINE safety ,INFLUENZA vaccines ,VACCINE effectiveness ,SOCIAL norms - Abstract
Despite the proven effectiveness of influenza vaccines, vaccination coverage remains suboptimal globally. Descriptive norms messaging highlighting low influenza vaccination rates is often presented to the public. This study investigated the influence of descriptive norms on influenza vaccination intentions and assessed whether the interaction of value framing with herd-immunity threshold moderates this effect. Utilizing an online experiment, a 2 (descriptive norms: 20% vs. 80%) × 2 (value framing: individual immunity vs. herd immunity) × 2 (herd-immunity threshold: uncertain vs. 90%) between-subjects fractional design was conducted with 803 participants (female 62%, mean age 31 years). The results revealed that low descriptive norms decreased influenza vaccination intention by amplifying concerns about the vaccine's safety and effectiveness. While framing the value of herd immunity increased vaccination intention when the herd-immunity threshold was uncertain, it did not mitigate the negative impact of low descriptive norms. These findings offer novel insights into the cognitive mechanisms underpinning norm-based social influence on vaccination intentions and suggest that public health officials should exercise caution when presenting vaccine coverage statistics to the public to avoid inadvertently discouraging vaccination. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
9. Impaired antigen-specific B-cell responses after Influenza vaccination in kidney transplant recipients receiving co-stimulation blockade with Belatacept.
- Author
-
Pernin, Vincent, Meneghini, Maria, Torija, Alba, Jouve, Thomas, Del Bello, Arnaud, Sanz-Muñoz, Iván, Maria Eiros, Jose, Donadeu, Laura, Polo, Carol, Morandeira, Francisco, Navarro, Sergio, Masuet, Cristina, Favà, Alexandre, LeQuintrec, Moglie, Kamar, Nassim, Crespo, Elena, and Bestard, Oriol
- Subjects
B cells ,BELATACEPT ,INFLUENZA vaccines ,KIDNEY transplantation ,HEPATITIS B vaccines ,HISTOCOMPATIBILITY antigens ,IMMUNOLOGIC memory ,HEMAGGLUTINATION tests - Abstract
Emerging data suggest that costimulation blockade with belatacept effectively controls humoral alloimmune responses. However, whether this effect may be deleterious for protective anti-infectious immunity remains poorly understood. We performed a mechanistic exploratory study in 23 kidney transplant recipients receiving either the calcineurin-inhibitor tacrolimus (Tac, n=14) or belatacept (n=9) evaluating different cellular immune responses after influenza vaccination such as activated T follicular Helper (Tfh), plasmablasts and H1N1 hemagglutinin (HA)-specific memory B cells (HA+mBC) by flow-cytometry, and anti-influenza antibodies by hemagglutination inhibition test (HI), at baseline and days 10, 30 and 90 post-vaccination. The proportion of CD4+CD54RACXCR5
+ Tfh was lower in belatacept than Tac patients at baseline (1.86%[1.25-3.03] vs 4.88%[2.40-8.27], p=0.01) and remained stable post-vaccination. At M3, HA+ mBc were significantly higher in Tac-treated patients (0.56%[0.32-1.49] vs 0.27%[0.13-0.44], p=0.04) and correlated with activated Tfh numbers. When stratifying patients according to baseline HA+ mBc frequencies, belatacept patients with low HA+mBC displayed significantly lower HA+mBc increases after vaccination than Tac patients (1.28[0.94-2.4] vs 2.54[1.73-5.70], p=0.04). Also, belatacept patients displayed significantly lower seroprotection rates against H1N1 at baseline than Tac-treated patients (44.4% vs 84.6%) as well as lower seroconversion rates at days 10, 30 and 90 after vaccination (50% vs 0%, 63.6% vs 0%, and 63.6% vs 0%, respectively). We show the efficacy of belatacept inhibiting T-dependent antigen-specific humoral immune responses, active immunization should be highly encouraged before starting belatacept therapy. [ABSTRACT FROM AUTHOR]- Published
- 2024
- Full Text
- View/download PDF
10. Racial and ethnic minority status in country of birth modifies racial and ethnic disparities in influenza vaccination among New York City adults.
- Author
-
Croft, John L., Teasdale, Chloe A., Fleary, Sasha, and Kelvin, Elizabeth A.
- Subjects
- *
INFLUENZA vaccines , *ETHNICITY , *MINORITIES , *ADULTS , *RACIAL inequality - Abstract
Understanding the relationship between race/ethnicity, birthplace, and health outcomes is important for reducing health disparities. This study assessed the relationship between racial/ethnic identity and minority racial/ethnic status in country of birth on influenza vaccination among New York City (NYC) adults. Using 2015–2019 data from NYC's Community Health Surveys, we assessed the association between racial/ethnic identity and racial/ethnic minority status in birth country with past year influenza vaccination, calculating prevalence differences per 100 and assessing interaction on the additive scale using linear binomial regression, and prevalence ratios and interaction on the multiplicative scale using log-binomial regression. Effect modification between race/ethnicity and minority racial/ethnic status in birth country was significant on the additive scale for Hispanic (p = 0.018) and Black (p = 0.025) adults and the multiplicative scale for Hispanic adults (p = 0.040). After stratifying by racial/ethnic minority or majority status in birth country, vaccination was significantly lower among Black adults compared with White adults among those in the minority (adjusted prevalence difference [aPD]=−12.98, 95%CI: −22.88-(−2.92)) and significantly higher among Hispanic adults compared with White adults among those in the majority (aPD=9.28, 95%CI: 7.35–11.21). Racial/ethnic minority status in birth country is an important factor when examining racial/ethnic differences in vaccination status. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
11. Improving Influenza Epidemiological Models under Caputo Fractional-Order Calculus.
- Author
-
E. Alsubaie, Nahaa, EL Guma, Fathelrhman, Boulehmi, Kaouther, Al-kuleab, Naseam, and A. Abdoon, Mohamed
- Subjects
- *
SEASONAL influenza , *FRACTIONAL calculus , *EPIDEMIOLOGICAL models , *INFLUENZA vaccines , *DIFFERENTIAL operators - Abstract
The Caputo fractional-order differential operator is used in epidemiological models, but its accuracy benefits are typically ignored. We validated the suggested fractional epidemiological seasonal influenza model of the SVEIHR type to demonstrate the Caputo operator's relevance. We analysed the model using fractional calculus, revealing its basic properties and enhancing our understanding of disease progression. Furthermore, the positivity, bounds, and symmetry of the numerical scheme were examined. Adjusting the Caputo fractional-order parameter α = 0.99 provided the best fit for epidemiological data on infection rates. We compared the suggested model with the Caputo fractional-order system and the integer-order equivalent model. The fractional-order model had lower absolute mean errors, suggesting that it could better represent sickness transmission and development. The results underline the relevance of using the Caputo fractional-order operator to improve epidemiological models' precision and forecasting. Integrating fractional calculus within the framework of symmetry helps us build more reliable models that improve public health interventions and policies. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
12. Patients with juvenile idiopathic arthritis have decreased clonal diversity in the CD8+ T cell repertoire response to influenza vaccination.
- Author
-
Sabbagh, Sara E., Haribhai, Dipica, Gershan, Jill A., Verbsky, James, Nocton, James, Yassai, Maryam, Naumova, Elena N., Hammelev, Erin, Dasgupta, Mahua, Ke Yan, Gorski, Jack, and Williams, Calvin B.
- Subjects
JUVENILE idiopathic arthritis ,T cells ,INFLUENZA vaccines ,IMMUNOSUPPRESSIVE agents - Abstract
Recurrent exposures to a pathogenic antigen remodel the CD8+ T cell compartment and generate a functional memory repertoire that is polyclonal and complex. At the clonotype level, the response to the conserved influenza antigen, M
158-66 has been well characterized in healthy individuals, but not in patients receiving immunosuppressive therapy or with aberrant immunity, such as those with juvenile idiopathic arthritis (JIA). Here we show that patients with JIA have a reduced number of M158-66 specific RS/RA clonotypes, indicating decreased clonal richness and, as a result, have lower repertoire diversity. By using a rank-frequency approach to analyze the distribution of the repertoire, we found several characteristics of the JIA T cell repertoire to be akin to repertoires seen in healthy adults, including an amplified RS/RA-specific antigen response, representing greater clonal unevenness. Unlike mature repertoires, however, there is more fluctuation in clonotype distribution, less clonotype stability, and more variable IFNy response of the M158-66 specific RS/RA clonotypes in JIA. This indicates that functional clonal expansion is altered in patients with JIA on immunosuppressive therapies. We propose that the response to the influenza M158-66 epitope described here is a general phenomenon for JIA patients receiving immunosuppressive therapy, and that the changes in clonal richness and unevenness indicate a retarded and uneven generation of a mature immune response. [ABSTRACT FROM AUTHOR]- Published
- 2024
- Full Text
- View/download PDF
13. Evaluating Factors That Influence Influenza Vaccination Uptake among Pregnant People in a Medically Underserved Area in Washington State.
- Author
-
McKeirnan, Kimberly, Brand, Damianne, Giruzzi, Megan, Vaitla, Kavya, Giruzzi, Nick, Krebill-Prather, Rose, and Dang, Juliet
- Subjects
MEDICAL personnel ,PREGNANT women ,FLU vaccine efficacy ,VACCINE safety ,VACCINE effectiveness - Abstract
Introduction: Despite substantial evidence demonstrating the effectiveness of influenza vaccines, only 38.6% of the adult United States population received an influenza vaccine during the 2023–2024 flu season. Vaccination rates are typically lower among U.S. minority groups, and in 2022, pregnant persons from U.S. minority racial and ethnic groups showed a decrease in influenza vaccine coverage. Methods: A survey was conducted with residents of Yakima County, Washington, which is home to one of the state's largest percentages of people who identify as Hispanic or Latino/a. The objective was to evaluate the uptake of influenza vaccine among pregnant persons. Surveys were sent to a random sample of 3000 residential mailing addresses. Of the 500 respondents, 244 (52.1%) reported that they had been pregnant, with those identifying as Hispanic or Latino/a constituting 23.8% of this total. Only 62 (26.2%) reported being immunized against influenza during pregnancy. Respondents who were immunized against influenza chose to be vaccinated to protect themselves from the flu (85.5%, n = 53); because a healthcare provider recommended getting vaccinated (85.5%, n = 53); to protect the baby from the flu (82.3%, n = 51); because it was available for free or low cost (62.9%, n = 39); and because vaccination was convenient (54.8%, n = 34). Qualitative evaluation identified that participants who were not vaccinated against influenza during pregnancy believed the vaccination was not needed, was not recommended by a healthcare provider, was difficult to access, they were against vaccination in general, or they were concerned about the safety and ingredients of the vaccine. Conclusion: Barriers to vaccination identified in this study included vaccine distrust, lack of awareness, and concerns about vaccine efficacy and safety. Healthcare providers can help address these concerns by providing education and recommendations about the importance of influenza vaccination during pregnancy. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
14. Influenza Vaccination Mediates SARS-CoV-2 Spike Protein Peptide-Induced Inflammatory Response via Modification of Histone Acetylation.
- Author
-
Zuo, Zejie, Mu, Yating, Qi, Fangfang, Zhang, Hongyang, Li, Zhihui, Zhou, Tuo, Guo, Wenhai, Guo, Kaihua, Hu, Xiquan, and Yao, Zhibin
- Subjects
SARS-CoV-2 ,MONONUCLEAR leukocytes ,COVID-19 ,HISTONE acetylation ,INFLUENZA vaccines - Abstract
The effectiveness of coronavirus disease 2019 (COVID-19) vaccines against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) strain rapidly wanes over time. Growing evidence from epidemiological studies suggests that influenza vaccination is associated with a reduction in the risk of SARS-CoV-2 infection and COVID-19 severity. However, the underlying mechanisms remain elusive. Here, we investigate the cross-reactive immune responses of influenza vaccination to SARS-CoV-2 spike protein peptides based on in vitro study. Our data indicate enhanced activation-induced-marker (AIM) expression on CD4+ T cells in influenza-vaccination (IV)-treated peripheral blood mononuclear cells (PBMCs) upon stimulation with spike-protein-peptide pools. The fractions of other immune cell subtypes, including CD8+ T cells, monocytes, NK cells, and antigen-presenting cells, were not changed between IV-treated and control PBMCs following ex vivo spike-protein-peptide stimulation. However, the classical antiviral (IFN-γ) and anti-inflammatory (IL-1RA) cytokine responses to spike-protein-peptide stimulation were still enhanced in PBMCs from both IV-immunized adult and aged mice. Decreased expression of proinflammatory IL-1β, IL-12p40, and TNF-α is associated with inhibited levels of histone acetylation in PBMCs from IV-treated mice. Remarkably, prior immunity to SARS-CoV-2 does not result in modification of histone acetylation or hemagglutinin-protein-induced cytokine responses. This response is antibody-independent but can be mediated by manipulating the histone acetylation of PBMCs. These data experimentally support that influenza vaccination could induce modification of histone acetylation in immune cells and reveal the existence of potential cross-reactive immunity to SARS-CoV-2 antigens, which may provide insights for the adjuvant of influenza vaccine to limit COVID-19-related inflammatory responses. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
15. Impact of Smoking Cessation and Charlson Comorbidity Index on Influenza Vaccination Efficacy in COPD Patients.
- Author
-
Chang, Hui-Chuan and Liu, Shih-Feng
- Subjects
EMERGENCY room visits ,CHRONIC obstructive pulmonary disease ,INFLUENZA vaccines ,SMOKING cessation ,MEDICAL care costs - Abstract
Chronic obstructive pulmonary disease (COPD) patients are particularly susceptible to respiratory infections like influenza, which exacerbate symptoms and increase healthcare utilization. While smoking cessation and influenza vaccination are recommended preventive measures, their combined impact on healthcare resource utilization is underexplored. The Charlson Comorbidity Index (CCI) assesses comorbidity burden in COPD patients and may influence healthcare outcomes. We conducted a retrospective analysis of 357 COPD patients, evaluating smoking cessation success over one year and influenza vaccination receipt, stratifying patients by CCI scores. Healthcare utilization outcomes included emergency room visits, hospitalizations, and medical expenses. Results showed that 51.82% of patients quit smoking and 59.66% received influenza vaccination, with higher comorbidity prevalence in advanced COPD stages (p = 0.002). Both smoking cessation and influenza vaccination independently correlated with decreased emergency room visits, hospital admissions, days, and costs. Patients who both quit smoking and received influenza vaccination exhibited the lowest healthcare utilization rates. In conclusion, smoking cessation and influenza vaccination significantly reduce healthcare resource utilization in COPD patients, with the combination yielding synergistic benefits, particularly in those with lower CCI scores. Integrating these interventions and comorbidity management in COPD strategies is essential for optimizing patient outcomes and healthcare efficiency. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
16. Socio-economic inequalities in the use of flu vaccination in Europe: a multilevel approach
- Author
-
Dănuț-Vasile Jemna, Mihaela David, Liliane Bonnal, and Cornel Oros
- Subjects
Preventive healthcare ,Influenza vaccination ,Socio-economic inequalities ,EHIS 2019 ,Multilevel logistic model. ,Medicine (General) ,R5-920 - Abstract
Abstract Background The European-wide statistics show that the use of flu vaccination remains low and the differences between countries are significant, as are those between different population groups within each country. Considerable research has focused on explaining vaccination uptake in relation to socio-economic and demographic characteristics, health promotion and health behavior factors. Nevertheless, few studies have aimed to analyze between-country differences in the use of flu vaccination for the EU population. To address this gap, this study examines the socio-economic inequalities in the use of influenza vaccination for the population aged 15 years and over in all 27 EU Member States and two other non-EU countries (Iceland and Norway). Methods Using data from the third wave of European Health Interview Survey (EHIS) 2019, we employed a multilevel logistic model with a random intercept for country, which allows controlling simultaneously the variations in individuals’ characteristics and macro-contextual factors which could influence the use of flu vaccination. In addition, the analysis considers the population stratified into four age groups, namely adolescents, young adults, adults and elderly, to better capture heterogeneities in flu vaccination uptake. Results The main findings confirm the existence of socio-economic inequalities between individuals in different age groups, but also of significant variation between European countries, particularly for older people, in the use of influenza vaccination. In this respect, income and education are strong proxy of socio-economic status associated with flu vaccination uptake. Moreover, these disparities within each population group are also explained by area of residence and occupational status. Particularly for the elderly, the differences between individuals in vaccine utilization are also explained by country-level factors, such as the type of healthcare system adopted in each country, public funding, personal health expenditure burden, or the availability of generalist practitioners. Conclusions Overall, our findings reveal that vaccination against seasonal influenza remains a critical public health intervention and bring attention to the relevance of conceiving and implementing context-specific strategies to ensure equitable access to vaccines for all EU citizens.
- Published
- 2024
- Full Text
- View/download PDF
17. Real world evidence for public health decision-making on vaccination policies: perspectives from an expert roundtable
- Author
-
Chiara de Waure, Barbara C. Gärtner, Pier Luigi Lopalco, Joan Puig-Barbera, and Jonathan S. Nguyen-Van-Tam
- Subjects
Influenza ,influenza vaccination ,vaccine effectiveness ,vaccination recommendations ,evidence base ,evaluation methodology ,Internal medicine ,RC31-1245 - Abstract
ABSTRACTIntroduction Influenza causes significant morbidity and mortality, but influenza vaccine uptake remains below most countries’ targets. Vaccine policy recommendations vary, as do procedures for reviewing and appraising the evidence.Areas Covered During a series of roundtable discussions, we reviewed procedures and methodologies used by health ministries in four European countries to inform vaccine recommendations. We review the type of evidence currently recommended by each health ministry and the range of approaches toward considering randomized controlled trials (RCTs) and real-world evidence (RWE) studies when setting influenza vaccine recommendations.Expert Opinion Influenza vaccine recommendations should be based on data from both RCTs and RWE studies of efficacy, effectiveness, and safety. Such data should be considered alongside health-economic, cost-effectiveness, and budgetary factors. Although RCT data are more robust and less prone to bias, well-designed RWE studies permit timely evaluation of vaccine benefits, effectiveness comparisons over multiple seasons in large populations, and detection of rare adverse events, under real-world conditions. Given the variability of vaccine effectiveness due to influenza virus mutations and increasing diversification of influenza vaccines, we argue that consideration of both RWE and RCT evidence is the best approach to more nuanced and timely updates of influenza vaccine recommendations.
- Published
- 2024
- Full Text
- View/download PDF
18. The Effect of Fact Versus Myth Messages on Receipt of Influenza Vaccination
- Author
-
National Institute on Aging (NIA)
- Published
- 2023
19. Study of Immune Responses to Influenza Vaccination
- Published
- 2023
20. Influenza Vaccination of Romanian Medical Students during COVID-19 Times: From Knowledge to Behavior.
- Author
-
Enciu, Bianca Georgiana, Păuna, Andreea Marilena, Chivu, Carmen Daniela, Săndulescu, Oana, Crispo, Anna, Diaconescu, Liliana Veronica, Drăgănescu, Anca Cristina, Crăciun, Maria-Dorina, Pițigoi, Daniela, and Aramă, Victoria
- Subjects
MEDICAL students ,INFLUENZA vaccines ,COVID-19 pandemic ,MEDICAL personnel ,VACCINATION ,ANTI-vaccination movement ,PUBLIC health education - Abstract
In Romania, influenza vaccination uptake among healthcare workers decreased over time despite access to the vaccine being constantly improved. The aim of this paper is to provide a comparative analysis of the knowledge and attitudes of Dental Medicine and Medicine students towards recommended vaccinations for healthcare workers, focusing on influenza vaccination. A cross-sectional study was conducted during the entire 2021–2022 academic year. Data were collected using 2 electronic questionnaires which were applied to the students from the Faculty of Medicine (n = 883) and, respectively, the Faculty of Dental Medicine of the Carol Davila University of Medicine and Pharmacy, Bucharest, Romania. The questionnaires were offered to 1187 students and completed by 911 students (response rate = 77%). Out of these, 85% (n = 778) identified the influenza vaccine as recommended; 35% (n = 321) reported getting an annual influenza vaccination; and 37% (333) reported getting an influenza vaccination in the previous season. Overall, 45% (n = 222) of the respondents who completed the questionnaires from October 2021 to February 2022 reported that they intend to get vaccinated against influenza in the 2021–2022 season and approximately 8% (n = 39) reported that they had already been vaccinated. The multivariable analysis showed that the habit of getting annually vaccinated against influenza as well as the knowledge that influenza vaccine is recommended for all healthcare workers were associated with a higher probability of intending to get vaccinated. The current study emphasizes the need to raise awareness among medical students regarding influenza vaccination and to involve medical education institutions, public health authorities, and healthcare facilities in promoting this vaccination among students since the influenza vaccine uptake rate among medical students included in this study was suboptimal. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
21. Timing of Assessment of Humoral and Cell-Mediated Immunity after Influenza Vaccination.
- Author
-
Otani, Naruhito, Nakajima, Kazuhiko, Yamada, Kumiko, Ishikawa, Kaori, Ichiki, Kaoru, Ueda, Takashi, Takesue, Yoshio, Yamamoto, Takuma, Higasa, Satoshi, Tanimura, Susumu, Inai, Yuta, and Okuno, Toshiomi
- Subjects
CELLULAR immunity ,HUMORAL immunity ,INFLUENZA vaccines ,FLU vaccine efficacy ,IMMUNE response - Abstract
Assessment of the immune response to influenza vaccines should include an assessment of both humoral and cell-mediated immunity. However, there is a lack of consensus regarding the timing of immunological assessment of humoral and cell-mediated immunity after vaccination. Therefore, we investigated the timing of immunological assessments after vaccination using markers of humoral and cell-mediated immunity. In the 2018/2019 influenza season, blood was collected from 29 healthy adults before and after vaccination with a quadrivalent inactivated influenza vaccine, and we performed serial measurements of humoral immunity (hemagglutination inhibition [HAI] and neutralizing antibody [NT]) and cell-mediated immunity (interferon-gamma [IFN-γ]). The HAI and NT titers before and after vaccination were strongly correlated, but no correlation was observed between the markers of cell-mediated and humoral immunity. The geometric mean titer and geometric mean concentration of humoral and cellular immune markers increased within 2 weeks after vaccination and had already declined by 8 weeks. This study suggests that the optimal time to assess the immune response is 2 weeks after vaccination. Appropriately timed immunological assessments can help ensure that vaccination is effective. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
22. Cost-Effectiveness of Adjuvanted Quadrivalent Influenza Vaccine for Adults over 65 in France.
- Author
-
Paccalin, Marc, Gavazzi, Gaëtan, Berkovitch, Quentin, Leleu, Henri, Moreau, Romain, Ciglia, Emanuele, Burlet, Nansa, and Mould-Quevedo, Joaquin F.
- Subjects
INFLUENZA vaccines ,COST effectiveness ,VACCINE effectiveness ,MEDICAL care costs ,ADULTS - Abstract
Background: In France, influenza accounts for an average of over one million consultations with GPs, 20,000 hospitalizations, and 9000 deaths per year, particularly among the over-65s. This study evaluates the cost-effectiveness of the adjuvanted quadrivalent influenza vaccine (aQIV) compared to standard (SD-QIV) and high-dose (HD-QIV) quadrivalent influenza vaccines for individuals aged 65 and older in France. Methods: The age-structured SEIR transmission model, calibrated to simulate a mean influenza season, incorporates a contact matrix to estimate intergroup contact rates. Epidemiological, economic, and utility outcomes are evaluated. Vaccine effectiveness and costs are derived from literature and national insurance data. Quality of life adjustments for influenza attack rates and hospitalizations are applied. Deterministic and probabilistic analyses are also conducted. Results: Compared to SD-QIV, aQIV demonstrates substantial reductions in healthcare utilization and mortality, avoiding 89,485 GP consultations, 2144 hospitalizations, and preventing 1611 deaths. Despite an investment of EUR 110 million, aQIV yields a net saving of EUR 14 million in healthcare spending. Compared to HD-QIV, aQIV saves 62 million euros on vaccination costs. Cost-effectiveness analysis reveals an incremental cost-effectiveness ratio of EUR 7062 per QALY. Conclusions: This study highlights the cost-effectiveness of aQIV versus SD-QIV and HD-QIV, preventing influenza cases, hospitalizations, and deaths. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
23. Non-specific effects of the inactivated influenza vaccine. A test-negative study: The inactivated influenza vaccine and SARS-CoV-2 infections.
- Author
-
Sellies, Anne Jasmijn, Knol, Mirjam J., de Melker, Hester E., Bruijning-Verhagen, Patricia C.J.L., and de Boer, Annemarijn R.
- Subjects
- *
FLU vaccine efficacy , *COVID-19 vaccines , *INFLUENZA vaccines , *SARS-CoV-2 - Abstract
Previous research suggested that the inactivated influenza vaccine (IIV) may protect against SARS-CoV-2 infection or a severe course of COVID-19. These findings were however based on cohort studies, that are prone to confounding by indication. We examined the association between IIV and SARS-Cov-2 infection in a Dutch population using a test-negative design. This test-negative case-control study was conducted in adults (≥60) who tested because of COVID-19 like symptoms at community SARS-CoV-2 testing locations in the Netherlands during the period of November 8th 2021-March 11th 2022. Information on receipt of IIV in October-November 2021 was routinely collected at each visit. Logistic regression was used to calculate unadjusted, partially (sex, age, education level) and fully adjusted (COVID-19 vaccination, IIV 2020) odds ratios (ORs) for receipt of IIV in SARS-CoV-2 positive versus negative subjects. Differential effects on SARS-CoV-2 risk by time since IIV were investigated by including an interaction term for calendar time: November 2021-January 2022 vs February-March 2022. In total, 1,832 participants were included in the main analysis, of whom 336 (18.3 %) had a positive SARS-CoV-2 test. No significant association between IIV and SARS-CoV-2 infection was found; fully adjusted OR of 1.07 (95 % CI: 0.78–1.49). The interaction term for time periods was not significant (1.04 [95 % CI: 0.51–2.15], p = 0.91). Results were robust in sensitivity analyses. While earlier observational studies suggested a protective non-specific effect of IIV and SARS-CoV-2 infections, this smaller, but well controlled test-negative design study does not suggest an effect, either positive or negative. Larger test-negative design studies, or alternative designs such as the self-controlled case series design are needed to confirm these findings and provide more definite answers on the topic. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
24. The multi-dimensional impact of different sources of information on influenza vaccination of college students in China.
- Author
-
Gao, Hao, Zhao, Qingting, Li, Lina, Bai, Xintong, and Guo, Difan
- Subjects
- *
INFLUENZA prevention , *STATISTICS on college students , *IMMUNIZATION , *SOCIAL media , *HEALTH attitudes , *INFLUENZA vaccines , *QUESTIONNAIRES , *UNIVERSITIES & colleges , *LOGISTIC regression analysis , *INFORMATION resources , *DESCRIPTIVE statistics , *HEALTH behavior , *COMMUNICATION , *PSYCHOLOGY of college students , *INTERPERSONAL relations , *HEALTH promotion , *PATIENTS' attitudes , *MEDIA exposure - Abstract
Objective: To explore whether/how the willingness of Chinese college students to receive the influenza vaccines in the sample is affected by different information channels. Participants: Two hundred and four volunteers were recruited to participate in an anonymous online survey. All participants were college students, mainly undergraduates (81.86%), with a higher proportion of women (56.86%). Methods: Participants answered anonymous questionnaires through the website, including demographic data (age, gender, education, etc.), media exposure channels and frequency, views and attitudes toward influenza vaccines, etc. An ordered logistic regression analysis was conducted to explore the effects of different information sources on influenza vaccination among college students. Results: Exposure to traditional media, digital media, and interpersonal communication promotes college students' understanding of influenza vaccines. Exposure to digital media alleviates college students' hesitation to vaccinate, while interpersonal interaction and digital media exposure promote college students' willingness to vaccinate. Conclusions: Digital media is increasingly important in the lives of Chinese college students to promote healthy behaviors such as influenza vaccinations. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
25. Comparison of the influenza vaccination coverage among high-risk people between the online registration system and walk-in service system in Bangkok, Thailand.
- Author
-
Ranai Sairuk, Kimihiro Nishino, Souphalak Inthaphatha, Nobuyuki Hamajima, and Eiko Yamamoto
- Subjects
INFLUENZA vaccines ,VACCINATION coverage ,THAI people ,MEDICAL personnel ,VACCINATION of children - Abstract
Until recently, the Thai national program of seasonal influenza vaccination for high-risk people has been using a walk-in service system. However, in 2020, an online registration system was introduced in Bangkok to improve vaccine coverage. This study aimed to compare the coverage of influenza vaccination between the walk-in service and online registration systems. The study participants included 374,710 Thai individuals who obtained an influenza vaccination from the national program in the Bangkok health region in 2018 (n = 162,214) and in 2020 (n = 212,496). The registration systems that were examined were the walk-in service system in 2018 and the online registration system in 2020. The characteristics of vaccine recipients and the vaccine coverage in each risk group and health facility level were compared between the two systems. Coverage comparison in Bangkok between the years 2018 and 2020 showed an increase in coverage, particularly among individuals who had an influenza vaccination at health facilities of the primary level and in the elderly and obesity groups. The coverage among children was lowest among all high-risk groups. To improve coverage in Thailand, the online registration system should be introduced in all regions. Additionally, information about influenza vaccination for children should be disseminated to parents using handbooks or by word-of-mouth from healthcare workers. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
26. Attitude to Co-Administration of Influenza and COVID-19 Vaccines among Pregnant Women Exploring the Health Action Process Approach Model.
- Author
-
Fallucca, Alessandra, Immordino, Palmira, Ferro, Patrizia, Mazzeo, Luca, Petta, Sefora, Maiorana, Antonio, Maranto, Marianna, Casuccio, Alessandra, and Restivo, Vincenzo
- Subjects
INFLUENZA vaccines ,COVID-19 vaccines ,MATERNAL health ,SURROGATE mothers ,HEALTH attitudes ,PREGNANT women - Abstract
Respiratory tract diseases caused by influenza virus and SARS-CoV-2 can represent a serious threat to the health of pregnant women. Immunological remodulation for fetus tolerance and physiological changes in the gestational chamber expose both mother and child to fearful complications and a high risk of hospitalization. Vaccines to protect pregnant women from influenza and COVID-19 are strongly recommended and vaccine co-administration could be advantageous to increase coverage of both vaccines. The attitude to accept both vaccines is affected by several factors: social, cultural, and cognitive-behavioral. In Palermo, Italy, during the 2021–2022 influenza season, a cross-sectional study was conducted to evaluate pregnant women's intention to adhere to co-administration of influenza and COVID-19 vaccines. The determinants of vaccination attitude were investigated through the administration of a questionnaire and the Health Action Process Approach theory was adopted to explore the cognitive behavioral aspects. Overall, 120 pregnant women were enrolled; mean age 32 years, 98.2% (n = 118) of Italian nationality and 25.2% (n = 30) with obstetric or pathological conditions of pregnancy at risk. Factors significantly associated with the attitude to co-administration of influenza and COVID-19 vaccines among pregnant women were: high level of education (OR = 13.96; p < 0.001), positive outcome expectations (OR = 2.84; p < 0.001), and self-efficacy (OR = 3.1; p < 0.001). Effective strategies to promote the co-administration of the influenza vaccine and the COVID-19 vaccine should be based on the communication of the benefits and positive outcomes of vaccine co-administration and on the adequate information of pregnant women. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
27. Influenza vaccination accuracy among adults: Self-report compared with electronic health record data.
- Author
-
Daley, Matthew F., Reifler, Liza M., Shoup, Jo Ann, Glanz, Jason M., Lewin, Bruno J., Klein, Nicola P., Kharbanda, Elyse O., McLean, Huong Q., Hambidge, Simon J., Nelson, Jennifer C., Naleway, Allison L., Weintraub, Eric S., McNeil, Michael M., Razzaghi, Hilda, and Singleton, James A.
- Subjects
- *
INFLUENZA vaccines , *ELECTRONIC health records , *DATA recorders & recording , *SELF-evaluation , *ADULTS - Abstract
To assess the validity of electronic health record (EHR)-based influenza vaccination data among adults in a multistate network. Following the 2018–2019 and 2019–2020 influenza seasons, surveys were conducted among a random sample of adults who did or did not appear influenza-vaccinated (per EHR data) during the influenza season. Participants were asked to report their influenza vaccination status; self-report was treated as the criterion standard. Results were combined across survey years. Survey response rate was 44.7% (777 of 1740) for the 2018–2019 influenza season and 40.5% (505 of 1246) for the 2019–2020 influenza season. The sensitivity of EHR-based influenza vaccination data was 75.0% (95% confidence interval [CI] 68.1, 81.1), specificity 98.4% (95% CI 92.9, 99.9), and negative predictive value 73.9% (95% CI 68.0, 79.3). In a multistate research network across two recent influenza seasons, there was moderate concordance between EHR-based vaccination data and self-report. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
28. Specific and Nonspecific Effects of Influenza Vaccines.
- Author
-
Principi, Nicola and Esposito, Susanna
- Subjects
INFLUENZA vaccines ,IMMUNIZATION of children ,VIRUS diseases ,COMMUNICABLE diseases ,VACCINE effectiveness - Abstract
With the introduction of the influenza vaccine in the official immunization schedule of most countries, several data regarding the efficacy, tolerability, and safety of influenza immunization were collected worldwide. Interestingly, together with the confirmation that influenza vaccines are effective in reducing the incidence of influenza virus infection and the incidence and severity of influenza disease, epidemiological data have indicated that influenza immunization could be useful for controlling antimicrobial resistance (AMR) development. Knowledge of the reliability of these findings seems essential for precise quantification of the clinical relevance of influenza immunization. If definitively confirmed, these findings can have a relevant impact on influenza vaccine development and use. Moreover, they can be used to convince even the most recalcitrant health authorities of the need to extend influenza immunization to the entire population. In this narrative review, present knowledge regarding these particular aspects of influenza immunization is discussed. Literature analysis showed that the specific effects of influenza immunization are great enough per se to recommend systematic annual immunization of younger children, old people, and all individuals with severe chronic underlying diseases. Moreover, influenza immunization can significantly contribute to limiting the emergence of antimicrobial resistance. The problem of the possible nonspecific effects of influenza vaccines remains unsolved. The definition of their role as inducers of trained immunity seems essential not only to evaluate how much they play a role in the prevention of infectious diseases but also to evaluate whether they can be used to prevent and treat clinical conditions in which chronic inflammation and autoimmunity play a fundamental pathogenetic role. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
29. Evaluation of behavioral economic strategies to raise influenza vaccination rates across a health system: Results from a randomized clinical trial
- Author
-
Szilagyi, Peter G, Casillas, Alejandra, Duru, O Kenrik, Ong, Michael K, Vangala, Sitaram, Tseng, Chi-Hong, Albertin, Christina, Humiston, Sharon G, Ross, Mindy K, Friedman, Sarah R, Evans, Sharon, Sloyan, Michael, Bogard, Jonathan E, Fox, Craig R, and Lerner, Carlos
- Subjects
Health Services and Systems ,Health Sciences ,Pneumonia & Influenza ,Emerging Infectious Diseases ,Influenza ,Clinical Research ,Social Determinants of Health ,Prevention ,Minority Health ,Coronaviruses ,Biodefense ,Health Disparities ,Clinical Trials and Supportive Activities ,Vaccine Related ,Infectious Diseases ,Immunization ,Infection ,Good Health and Well Being ,Adult ,Child ,Humans ,Influenza Vaccines ,Influenza ,Human ,Economics ,Behavioral ,Pandemics ,Reminder Systems ,COVID-19 ,Vaccination ,Influenza vaccination ,Patient portal ,Behavioral economics ,Randomized clinical trial ,Human Movement and Sports Sciences ,Public Health and Health Services ,Public Health ,Epidemiology ,Public health - Abstract
Influenza vaccination rates are low. Working with a large US health system, we evaluated three health system-wide interventions using the electronic health record's patient portal to improve influenza vaccination rates. We performed a two-arm RCT with a nested factorial design within the treatment arm, randomizing patients to usual-care control (no portal interventions) or to one or more portal interventions. We included all patients within this health system during the 2020-2021 influenza vaccination season, which overlapped with the COVID-19 pandemic. Through the patient portal, we simultaneously tested: pre-commitment messages (sent September 2020, asking patients to commit to a vaccination); monthly portal reminders (October - December 2020), direct appointment scheduling (patients could self-schedule influenza vaccination at multiple sites); and pre-appointment reminder messages (sent before scheduled primary care appointments, reminding patients about influenza vaccination). The main outcome measure was receipt of influenza vaccine (10/01/2020-03/31/2021). We randomized 213,773 patients (196,070 adults ≥18 years, 17,703 children). Influenza vaccination rates overall were low (39.0%). Vaccination rates for study arms did not differ: Control (38.9%), pre-commitment vs no pre-commitment (39.2%/38.9%), direct appointment scheduling yes/no (39.1%/39.1%), pre-appointment reminders yes/no (39.1%/39.1%); p > 0.017 for all comparisons (p value cut-off adjusted for multiple comparisons). After adjusting for age, gender, insurance, race, ethnicity, and prior influenza vaccination, none of the interventions increased vaccination rates. We conclude that patient portal interventions to remind patients to receive influenza vaccine during the COVID-19 pandemic did not raise influenza immunization rates. More intensive or tailored interventions are needed beyond portal innovations to increase influenza vaccination.
- Published
- 2023
30. Strategies used to improve vaccine uptake among healthcare providers: A systematic review
- Author
-
Rosaline de Koning, Mariana Gonzalez Utrilla, Emma Spanaus, Michael Moore, and Marta Lomazzi
- Subjects
Vaccine uptake ,Health workforce ,Public health ,Prevention ,Influenza vaccination ,Immunologic diseases. Allergy ,RC581-607 - Abstract
Background: Vaccination is one of the most effective available public health tools, preventing infectious diseases to safeguard public health and save millions of lives annually. However, in recent years vaccine hesitancy has increased among all populations, including healthcare workers. Healthcare providers are central to vaccination efforts due to their increased exposure to disease and vulnerable patients, and their role in patient confidence and decision-making. These decreasing uptake rates highlight a critical need to address specific barriers within this target group. This systematic review aims to explore the strategies used to improve vaccine uptake among healthcare providers. Methods: A literature search was conducted in PubMed, EMBASE, and MEDLINE databases, alongside a grey literature search, to identify studies describing interventions to improve vaccine uptake among healthcare providers. This was followed by de-duplication and double-blinded screening processes using Rayyan. Data extraction and thematic analysis focused on categorising interventions and identifying frequencies of use, to develop recommendations for further interventions tailored to target regions. Results: 60 studies were identified, predominantly concerning influenza vaccination. Interventions included educational initiatives, reminders, incentives, access solutions, feedback, and policy implementation. Key strategies included targeted educational lectures, posters, and pamphlets; mobile vaccination units; extended vaccination hours; and leadership engagement. The findings underscore the importance of a multifaceted approach combining educational efforts, enhanced accessibility, and motivational incentives to improve vaccination rates within the healthcare providers, especially where mandatory vaccination is controversial. Conclusions: This review evaluates tailored strategies to enhance vaccine confidence and uptake among healthcare providers, advocating for a holistic approach that includes educational initiatives, reminder systems, incentives, improved access, feedback mechanisms, and policy enactment to effectively address hesitancy and promote public health.
- Published
- 2024
- Full Text
- View/download PDF
31. Parental knowledge, attitudes, and practices toward vaccinating their children against influenza: a cross-sectional study from China
- Author
-
Shufeng He, Caijin Zhu, Xiaoyan Liu, and Yanling Wang
- Subjects
parents ,influenza vaccination ,knowledge ,China ,attitude ,Public aspects of medicine ,RA1-1270 - Abstract
AimsInfluenza infection is a health burden in children, and the influenza vaccine is an important prevention strategy for flu illness. Parents play a crucial role in children’s influenza vaccination. The study aimed to assess parental knowledge, attitudes, and practices (KAP) related to influenza illness for their children and explore factors that may impact their decisions.MethodsThis cross-sectional study was conducted in a tertiary hospital in Guangzhou from November 2022 to April 2023. Answers to KAP questions regarding influenza illness and vaccination were summed, with a total KAP score of 20. Univariate and multivariate logistic regression models and linear regression models were conducted to explore the factors associated with influenza vaccination. The results were presented as odds ratios (ORs), β, and 95% confidence intervals (CIs).ResultsOverall, 530 parents were respondents, of whom 162 (30.56%) had vaccinated their children during the past year. The mean KAP score (standard deviation) was 13.40 (3.57). Compared to parents who reported non-vaccinated for their children in the past year, the parents who reported an influenza vaccination have higher knowledge scores, attitude scores, practice scores, and total scores. Child body mass index, parental education level (under college), parental work (part-time), and more than two family members over 60 years old were negatively correlated with knowledge score. Child health condition and knowledge score were positively correlated with attitude score. Parental age was negatively associated with attitude score.ConclusionThough high awareness about influenza illness and vaccination for parents, the coverage rate of influenza vaccination in children was lower in Guangzhou. Implementing public health policies is necessary to spread knowledge about influenza illness and vaccination and to promote the practice of receiving the influenza vaccine in children. Education campaigns would help change the attitudes of parents toward vaccinating their children against the flu.
- Published
- 2024
- Full Text
- View/download PDF
32. Corrigendum: Impaired antigen-specific B-cell responses after Influenza vaccination in kidney transplant recipients receiving co-stimulation blockade with Belatacept
- Author
-
Vincent Pernin, Maria Meneghini, Alba Torija, Thomas Jouve, Arnaud Del Bello, Iván Sanz-Muñoz, Jose Maria Eiros, Laura Donadeu, Carol Polo, Francisco Morandeira, Sergio Navarro, Cristina Masuet, Alexandre Favà, Moglie LeQuintrec, Nassim Kamar, Elena Crespo, and Oriol Bestard
- Subjects
kidney transplantation ,co-stimulation blockade ,memory B cells ,influenza vaccination ,calcineurin inhibitors ,T follicular helper (Tfh) cell ,Immunologic diseases. Allergy ,RC581-607 - Published
- 2024
- Full Text
- View/download PDF
33. Building and Sustaining Flu Vaccine Acceptance and Trust in the Black Community through Partnerships with Churches, Salons, and Barbershops
- Author
-
Nuss, Henry, Privor-Dumm, Lois, Ukachukwu, Chinonso, and Hall, Laura Lee
- Published
- 2024
- Full Text
- View/download PDF
34. The economic and fiscal impact of incremental use of cell-based quadrivalent influenza vaccine for the prevention of seasonal influenza among healthcare workers in Italy
- Author
-
Giovanna Elisa Calabrò, Filippo Rumi, Roberto Ricciardi, and Americo Cicchetti
- Subjects
Economic impact ,Influenza vaccination ,Healthcare workers ,Cell-based quadrivalent influenza vaccine ,Public aspects of medicine ,RA1-1270 - Abstract
Abstract Background Seasonal influenza has a significant impact on public health, generating substantial direct healthcare costs, production losses and fiscal effects. Understanding these consequences is crucial to effective decision-making and the development of preventive strategies. This study aimed to evaluate the economic and the fiscal impact of implementing an incremental strategy for seasonal influenza prevention using the cell-based quadrivalent influenza vaccine (QIVc) among healthcare workers (HCWs) in Italy. Methods To estimate the economic impact of implementing this strategy, we performed a cost analysis that considered direct healthcare costs, productivity losses and fiscal impact. The analysis considered a 3-year time horizon. A deterministic sensitivity analysis was also conducted. Results Assuming a vaccination coverage rate of 30% among HCWs, the analysis considered a total of 203 018 vaccinated subjects. On analysing the overall differential impact (including direct costs, indirect costs and fiscal impact), implementing QIVc vaccination as a preventative measure against influenza among HCWs in Italy would yield societal resource savings of €23 638.78 in the first year, €47 277.56 in the second year, and €70 916.35 in the third year, resulting in total resource savings of €141 832.69. Conclusions The study demonstrated that implementing the incremental use of QIVc as part of a preventive strategy for seasonal influenza among HCWs in Italy could yield positive economic outcomes, especially in terms of indirect costs and fiscal impact. The resources saved could be utilized to fund further public health interventions. Policy-makers should consider these findings when making decisions regarding influenza prevention strategies targeting HCWs.
- Published
- 2024
- Full Text
- View/download PDF
35. Analysis of viral pneumonia and risk factors associated with severity of influenza virus infection in hospitalized patients from 2012 to 2016
- Author
-
M. I. Fullana Barceló, F. Artigues Serra, A. R. Millan Pons, J. Asensio Rodriguez, A. Ferre Beltran, M. del Carmen Lopez Bilbao, J. Reina Prieto, and M. Riera Jaume
- Subjects
Influenza risk factors ,Coinfection ,Influenza vaccination ,Infectious and parasitic diseases ,RC109-216 - Abstract
Abstract Background Influenza viruses cause pneumonia in approximately one-third of cases, and pneumonia is an important cause of death. The aim was to identify risk factors associated with severity and those that could predict the development of pneumonia. Methods This retrospective, observational study included all adult patients with confirmed influenza virus infection admitted to Son Espases University Hospital during four influenza seasons in Spain (October to May) from to 2012–2016. Results Overall, 666 patients with laboratory-confirmed influenza were included, 93 (14%) of which were severe; 73 (10.9%) were admitted to Intensive Care Unit (ICU), 39 (5.8%) died, and 185 (27.7%) developed pneumonia. Compared to less severe cases, patients with severe disease: were less vaccinated (40% vs. 28%, p = 0.021); presented with more confusion (26.9% vs. 6.8%), were more hypoxemic (Horowitz index (PaO2/FiO2) 261 vs. 280), had higher C-reactive protein (CRP) (12.3 vs. 4.0), had more coinfections (26.8% vs. 6.3%) and had more pleural effusion (14% vs. 2.6%) (last six all p
- Published
- 2024
- Full Text
- View/download PDF
36. Influenza vaccination before and during the COVID-19 pandemic in the elderly in South Korea
- Author
-
Dong Jun Kim, Kyoung Hee Cho, Seongju Kim, and Hooyeon Lee
- Subjects
Influenza ,Vaccine ,Elderly ,COVID-19 ,Influenza vaccination ,Infectious and parasitic diseases ,RC109-216 ,Public aspects of medicine ,RA1-1270 - Abstract
Background: Influenza epidemics are a significant cause of mortality and morbidity in older adults; thus, vaccination is recommended. However, the coronavirus disease 2019 (COVID-19) pandemic could affect influenza vaccination. Methods: The influenza vaccination rate was estimated from the Korea Community Health Survey data from 2011 to 2021 using Joinpoint regression. We used multiple logistic regression analysis from each two flu seasons data before (2017–18 and 2018–19 seasons) and during (2019–20 and 2020–21 seasons) the COVID-19 pandemic to identify older adults who were not been vaccinated during the COVID-19 pandemic. Additionally, we stratified changes in influenza vaccination according to the flu season, demographic and socioeconomic characteristics, and health status. Results: The annual percentage change in influenza non-vaccination rate from 2010–11 to 2018–19 seasons and from 2019–20 to 2020–21 seasons was -8.31% (confidence interval (CI), -9.60 to ‐7.00) and 11.41% (CI, -3.22 to 28.25), respectively. Compared to before COVID-19, in the 2019–20 and 2020–21 seasons, the odds ratio (OR) of non-vaccination was 0.87 (CI, 0.83–0.91) and 1.18 (95% CI, 1.13–1.24), respectively. The decrease in influenza vaccination among older individuals with higher education (OR, 1.24; CI, 1.11–1.39) was greater than that among those with lower education (OR, 1.09; CI, 0.98–1.22). Older individuals with the lowest income level or poor self-rated health showed reduced influenza vaccination. Conclusions: We estimated the trends of influenza vaccination and identified subgroups with decreased vaccination rates during the COVID-19 pandemic among older adults in South Korea. Health policy decision-makers, practitioners, and researchers should consider the implications of COVID-19 on changes in influenza vaccination, particularly for older individuals at risk of influenza.
- Published
- 2024
- Full Text
- View/download PDF
37. Humoral immunity and safety of respiratory virus vaccines in systemic lupus erythematosus population: a meta-analysis based on twenty-five observational studies
- Author
-
Xiao-Zheng Li, Ya-Wei Li, Cheng-Yang Huang, Jia-Ling Liu, Run-Ben Liu, Zhi-Xin Zhang, Jin-Zhu Yan, and Chao Zhang
- Subjects
Systemic lupus erythematosus ,influenza vaccination ,COVID-19 vaccination ,seroconversion rate ,neutralizing antibody ,adverse events ,Medicine - Abstract
Background Systemic lupus erythematosus (SLE), an extensive autoimmune disorder, compromises viral resistance and alters immune responses post respiratory virus vaccines. This study aims to assess immune response levels and safety in SLE patients following respiratory virus vaccines.Methods Extensive searches, until 1 March 2024, were conducted using PubMed, EMBASE, and Cochrane Library. Outcomes, encompassing seroconversion rate (SCR), antibody and IgG titers, neutralizing antibodies, anti-spike antibodies, anti-receptor binding domain (RBD) IgG, and adverse events, were appraised.Results Sixteen articles, comprising 25 observational studies, were included. SLE patients exhibited lower SCR (OR = 0.42, 95%CI: 0.26 to 0.69), antibody titers (SMD=-2.84, 95%CI: −3.36 to −1.61), and neutralizing antibodies (OR = 0.27, 95%CI: 0.13 to 0.56) compared to the healthy population post respiratory virus vaccines. Notably, differences were statistically insignificant for anti-RBD IgG (OR = 1.75, 95%CI: 0.10 to 29.42), IgG titers (SMD=-2.54, 95%CI: −5.57 to −0.49), anti-spike antibodies (OR = 0.35, 95%CI: 0.08 to 1.53), injection site discomfort (OR = 1.03, 95%CI: 0.52 to 2.06), fatigue (OR = 1.23, 95%CI: 0.74 to 2.03), fever (OR = 1.02, 95%CI: 0.64 to 1.63), localized reactions (OR = 0.69, 95%CI: 0.37 to 1.30), systemic reactions (OR = 1.00, 95%CI: 0.59 to 1.69), allergic reactions (OR = 5.11, 95%CI: 0.24 to 107.10), self-reported vaccination-related adverse events (OR = 1.61, 95%CI: 0.56 to 4.63), and disease flares after vaccination (OR = 1.00, 95%CI: 0.14 to 7.28).Conclusion Despite the reduced immune response and host protection in SLE patients post-Corona Virus Disease 2019 (COVID-19) and influenza vaccines compared to the healthy population, safety profiles are comparable. Therefore, it is recommended that SLE patients receive COVID-19 and influenza viral vaccines to fortify their resistance.
- Published
- 2024
- Full Text
- View/download PDF
38. Parent and family characteristics associated with reported pediatric influenza vaccination in a sample of Canadian digital vaccination platform users. An exploratory, cross-sectional study in the 2018-2019 influenza season
- Author
-
Katherine Atkinson, Blaise Ntacyabukura, Steven Hawken, Ziad El-Khatib, Lucie Laflamme, and Kumanan Wilson
- Subjects
Influenza vaccination ,parental characteristics ,immunization programs ,digital health records ,vaccination coverage ,Immunologic diseases. Allergy ,RC581-607 ,Therapeutics. Pharmacology ,RM1-950 - Abstract
Seasonal vaccination remains one of the best interventions to prevent morbidity and mortality from influenza in children. Understanding the characteristics of parents who vaccinate their children can inform communication strategies to encourage immunization. Using a cross-sectional study, we described parental characteristics of people who reported vaccinating their children against influenza during 2018/2019 in a cohort of Canadian digital immunization record users. Data was collected from a free, Pan-Canadian digital vaccination tool, CANImmunize. Eligible accounts contained at least one parental and one “child/dependent” record. Each parental characteristic (gender, age, family size, etc) was tested for association with pediatric influenza vaccination, and a multivariate logistic regression model was fit. A total of 6,801 CANImmunize accounts met inclusion criteria. After collapsing the dataset, the final sample contained 11,381 unique dyads. Influenza vaccination was reported for 32.3% of the children and 42.0% of the parents. In the multivariate logistic regression analysis, parents receiving the seasonal influenza vaccine were most strongly associated with reporting pediatric influenza vaccination (OR 17.05, 95% CI 15.08, 19.28). Having a larger family size and fewer transactions during the study period was associated with not reporting pediatric influenza vaccination. While there are several limitations to this large-scale study, these results can help inform future research in the area. Digital technologies may provide a unique and valuable source of vaccine coverage data and to explore associations between individual characteristics and immunization behavior. Policy makers considering digital messaging may want to tailor their efforts based on parental characteristics to further improve pediatric seasonal influenza vaccine uptake.
- Published
- 2024
- Full Text
- View/download PDF
39. Changes of influenza vaccination rate and associated influencing factors after the COVID-19 pandemic in Shanghai, China
- Author
-
Geyang Sun, Li Zhang, Ye Qiu, Yilin Jia, Yuanping Wang, Hongmei Xu, Anran Zhang, Lipeng Hao, Weiping Zhu, and Chuchu Ye
- Subjects
Influenza vaccination ,COVID-19 ,coverage ,children ,elder people ,Immunologic diseases. Allergy ,RC581-607 ,Therapeutics. Pharmacology ,RM1-950 - Abstract
ABSTRACTThe vaccination rate for seasonal influenza remains low in most regions of China. It is essential to understand the factors that associated with the low influenza vaccination rate in various populations after the COVID-19 pandemic. A cross-sectional survey was conducted with residents in Pudong New Area, Shanghai, China. Respondents’ vaccination condition during the 2021–2022 flu season and the reasons for receiving or not receiving influenza vaccine were investigated. Binary logistic regression was conducted to explore potential factors influencing vaccination uptake. 2,476 of 14,001 respondents received an influenza vaccine, with a total coverage of 17.68% (95% CI: 17.05%, 18.32%). Children had the highest vaccination coverage (35.68%; 95% CI: 34.02, 37.33), followed by adults (12.75%; 95% CI: 11.91%, 13.58%) and elderly individuals (11.70%, 95% CI: 10.78%, 12.62%). For children, lower household income was an significant promoting factor. For adults, factors significantly associated with vaccination were household income, sex, and education level. For elderly, factors significantly associated with vaccination were household income, education level, living state, and having underlying diseases. (P
- Published
- 2024
- Full Text
- View/download PDF
40. The economic and fiscal impact of incremental use of cell-based quadrivalent influenza vaccine for the prevention of seasonal influenza among healthcare workers in Italy.
- Author
-
Calabrò, Giovanna Elisa, Rumi, Filippo, Ricciardi, Roberto, and Cicchetti, Americo
- Abstract
Background: Seasonal influenza has a significant impact on public health, generating substantial direct healthcare costs, production losses and fiscal effects. Understanding these consequences is crucial to effective decision-making and the development of preventive strategies. This study aimed to evaluate the economic and the fiscal impact of implementing an incremental strategy for seasonal influenza prevention using the cell-based quadrivalent influenza vaccine (QIVc) among healthcare workers (HCWs) in Italy. Methods: To estimate the economic impact of implementing this strategy, we performed a cost analysis that considered direct healthcare costs, productivity losses and fiscal impact. The analysis considered a 3-year time horizon. A deterministic sensitivity analysis was also conducted. Results: Assuming a vaccination coverage rate of 30% among HCWs, the analysis considered a total of 203 018 vaccinated subjects. On analysing the overall differential impact (including direct costs, indirect costs and fiscal impact), implementing QIVc vaccination as a preventative measure against influenza among HCWs in Italy would yield societal resource savings of €23 638.78 in the first year, €47 277.56 in the second year, and €70 916.35 in the third year, resulting in total resource savings of €141 832.69. Conclusions: The study demonstrated that implementing the incremental use of QIVc as part of a preventive strategy for seasonal influenza among HCWs in Italy could yield positive economic outcomes, especially in terms of indirect costs and fiscal impact. The resources saved could be utilized to fund further public health interventions. Policy-makers should consider these findings when making decisions regarding influenza prevention strategies targeting HCWs. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
41. Analysis of viral pneumonia and risk factors associated with severity of influenza virus infection in hospitalized patients from 2012 to 2016.
- Author
-
Fullana Barceló, M. I., Artigues Serra, F., Millan Pons, A. R., Asensio Rodriguez, J., Ferre Beltran, A., del Carmen Lopez Bilbao, M., Reina Prieto, J., and Riera Jaume, M.
- Subjects
- *
VIRUS diseases , *INFLUENZA viruses , *HOSPITAL patients , *PNEUMONIA , *PLEURAL effusions - Abstract
Background: Influenza viruses cause pneumonia in approximately one-third of cases, and pneumonia is an important cause of death. The aim was to identify risk factors associated with severity and those that could predict the development of pneumonia. Methods: This retrospective, observational study included all adult patients with confirmed influenza virus infection admitted to Son Espases University Hospital during four influenza seasons in Spain (October to May) from to 2012–2016. Results: Overall, 666 patients with laboratory-confirmed influenza were included, 93 (14%) of which were severe; 73 (10.9%) were admitted to Intensive Care Unit (ICU), 39 (5.8%) died, and 185 (27.7%) developed pneumonia. Compared to less severe cases, patients with severe disease: were less vaccinated (40% vs. 28%, p = 0.021); presented with more confusion (26.9% vs. 6.8%), were more hypoxemic (Horowitz index (PaO2/FiO2) 261 vs. 280), had higher C-reactive protein (CRP) (12.3 vs. 4.0), had more coinfections (26.8% vs. 6.3%) and had more pleural effusion (14% vs. 2.6%) (last six all p < 0.001). Risk factors significantly associated with severity were pneumonia [OR (95% CI) = 4.14 (2.4–7.16)], history of heart disease (1.84, 1.03–3.28), and confusion at admission (4.99, 2.55–9.74). Influenza vaccination was protective (0.53, 0.28–0.98). Compared to those without pneumonia, the pneumonia group had higher CRP (11.3 vs. 4.0, p < 0.001), lower oxygen saturation (92% vs. 94%, p < 0.001), were more hypoxic (PaO2/FiO2 266 vs. 281, p < 0.001), and incurred more mechanical ventilation, septic shock, admission to the ICU, and deaths (all four p < 0.001). Higher CRP and lower oxygen saturation were independent variables for predicting the development of pneumonia. Conclusions: Pneumonia, history of heart disease, confusion and no influenza vaccination were independent variables to present complications in patients admitted with influenza infection. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
42. The coverage of influenza vaccination and predictors of influenza non-vaccination in Danish cancer patients: A nationwide register-based cohort study.
- Author
-
Amdisen, Lau, Pedersen, Lars, Abildgaard, Niels, Benn, Christine Stabell, Rørth, Mikael, Cronin-Fenton, Deirdre, and Sørup, Signe
- Subjects
- *
INFLUENZA vaccines , *DANES , *VACCINATION coverage , *CANCER patients , *FLU vaccine efficacy , *COHORT analysis - Abstract
Influenza vaccination is recommended and provided free-of-charge to Danish citizens aged ≥65 years and to individuals with acquired immunodeficiency. We aimed to estimate influenza vaccination coverage and investigate predictors of influenza non-vaccination in Danish cancer patients. A nationwide cohort study of all Danish citizens aged ≥18 years with an incident cancer diagnosis between 2002 and 2017. Using national registries, we assessed information on influenza vaccination and potential predictors of influenza non-vaccination. We estimated adjusted prevalence ratios (aPR) of influenza non-vaccination for patients aged <65 years and ≥65 years. We observed 269,863 patients during 840,876 influenza vaccination seasons. The influenza vaccination coverage was 14 % for cancer patients <65 years and 51 % for those ≥65 years. No influenza vaccination in the previous season was associated with non-vaccination in the current season (<65 years: aPR = 2.75, 95 %CI = 2.71–2.80; ≥65 years: aPR = 5.15, 95 %CI = 5.10–5.21). Haematological cancer patients receiving chemotherapy had lower vaccination prevalence compared with those not receiving chemotherapy. The influenza vaccination coverage was low among cancer patients. Influenza non-vaccination in the previous season was the strongest predictor of not receiving influenza vaccination in the current season. Haematological cancer patients on current chemotherapy had lower vaccination prevalence than those not currently receiving chemotherapy. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
43. Single-cell analytical technologies: uncovering the mechanisms behind variations in immune responses.
- Author
-
Yukie Kashima, Reteng, Patrick, Yasuhiko Haga, Junya Yamagishi, and Yutaka Suzuki
- Subjects
- *
IMMUNE response , *COVID-19 , *VIRAL transmission , *B cell receptors , *T cell receptors - Abstract
The immune landscape varies among individuals. It determines the immune response and results in surprisingly diverse symptoms, even in response to similar external stimuli. However, the detailed mechanisms underlying such diverse immune responses have remained mostly elusive. The utilization of recently developed single-cell multimodal analysis platforms has started to answer this question. Emerging studies have elucidated several molecular networks that may explain diversity with respect to age or other factors. An elaborate interplay between inherent physical conditions and environmental conditions has been demonstrated. Furthermore, the importance of modifications by the epigenome resulting in transcriptome variation among individuals is gradually being revealed. Accordingly, epigenomes and transcriptomes are direct indicators of the medical history and dynamic interactions with environmental factors. Coronavirus disease 2019 (COVID-19) has recently become one of the most remarkable examples of the necessity of in-depth analyses of diverse responses with respect to various factors to improve treatment in severe cases and to prevent viral transmission from asymptomatic carriers. In fact, determining why some patients develop serious symptoms is still a pressing issue. Here, we review the current "state of the art" in single-cell analytical technologies and their broad applications to healthy individuals and representative diseases, including COVID-19. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
44. Influenza vaccination before and during the COVID-19 pandemic in the elderly in South Korea.
- Author
-
Kim, Dong Jun, Cho, Kyoung Hee, Kim, Seongju, and Lee, Hooyeon
- Abstract
Influenza epidemics are a significant cause of mortality and morbidity in older adults; thus, vaccination is recommended. However, the coronavirus disease 2019 (COVID-19) pandemic could affect influenza vaccination. The influenza vaccination rate was estimated from the Korea Community Health Survey data from 2011 to 2021 using Joinpoint regression. We used multiple logistic regression analysis from each two flu seasons data before (2017–18 and 2018–19 seasons) and during (2019–20 and 2020–21 seasons) the COVID-19 pandemic to identify older adults who were not been vaccinated during the COVID-19 pandemic. Additionally, we stratified changes in influenza vaccination according to the flu season, demographic and socioeconomic characteristics, and health status. The annual percentage change in influenza non-vaccination rate from 2010–11 to 2018–19 seasons and from 2019–20 to 2020–21 seasons was -8.31% (confidence interval (CI), -9.60 to ‐7.00) and 11.41% (CI, -3.22 to 28.25), respectively. Compared to before COVID-19, in the 2019–20 and 2020–21 seasons, the odds ratio (OR) of non-vaccination was 0.87 (CI, 0.83–0.91) and 1.18 (95% CI, 1.13–1.24), respectively. The decrease in influenza vaccination among older individuals with higher education (OR, 1.24; CI, 1.11–1.39) was greater than that among those with lower education (OR, 1.09; CI, 0.98–1.22). Older individuals with the lowest income level or poor self-rated health showed reduced influenza vaccination. We estimated the trends of influenza vaccination and identified subgroups with decreased vaccination rates during the COVID-19 pandemic among older adults in South Korea. Health policy decision-makers, practitioners, and researchers should consider the implications of COVID-19 on changes in influenza vaccination, particularly for older individuals at risk of influenza. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
45. The Role of Pharmacists in Counteracting Vaccine Hesitancy: Effectiveness of the 2019 Carnia Project in Improving Adherence to Influenza Vaccination among Target Population.
- Author
-
Longobardi, Gloria, Brunelli, Laura, Piciocchi, Benedetta, Morsanutto, Andrea, Iob, Andrea, Schiava, Flavio, Pancino, Claudio Luigi, Degrassi, Luca, Tonutti, Giuseppe, Brusaferro, Silvio, and Arnoldo, Luca
- Subjects
VACCINE hesitancy ,INFLUENZA vaccines ,VACCINE effectiveness ,PHARMACISTS ,PUBLIC health - Abstract
Vaccine hesitancy has been included among the top ten threats to global health by the World Health Organization. Pharmacists can play a pivotal role in removing the individual barrier to vaccination, because of the relationship of trust they have with citizens and their ease of access. The aim of this study was to examine the impact of a pharmacy-based intervention to support the 2019 influenza vaccination campaign conducted in the Carnia district through one-to-one counseling. We analyzed data collected by pharmacists between 22 October 2019 and 20 January 2020, and trends in vaccination adherence in the context of the Local Health Authority and the entire province of Udine since 2016. The results showed that 77.2% of people who had not received an influenza vaccination in the previous year changed their minds about vaccination after receiving counseling. The pharmacy-based intervention improved influenza vaccination adherence in the target district (+13.4%), even when compared to the neighboring district of Gemona or considering the data in the broader local and provincial context, and this effect was particularly pronounced among those aged 65 to 74 years (p < 0.01). Considering these findings, pharmacies should be more effectively involved in the provision of public health services aimed at improving accessibility, timeliness, and equity. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
46. Web-based intervention for improving influenza vaccination in pregnant women: a cost-effectiveness analysis.
- Author
-
Wang, Yingcheng, Fekadu, Ginenus, and You, Joyce H.S.
- Subjects
PREGNANT women ,INFLUENZA vaccines ,MEDICAL personnel ,MONTE Carlo method ,VACCINATION status - Abstract
A website with vaccine information and interactive social media was reported to improve maternal influenza vaccine uptake. This study aimed to evaluate cost-effectiveness of a web-based intervention on influenza vaccine uptake among pregnant women from the perspective of US healthcare providers. A one-year decision-analytic model estimated outcomes in a hypothetical cohort of pregnant women with: (1) website with vaccine information and interactive social media (intervention group), and (2) usual care (usual care group). Primary measures included influenza infection, influenza-related hospitalization, mortality, direct medical cost, and quality-adjusted life-year (QALY) loss. In base-case analysis, intervention group reduced cost (by USD28), infection (by 28 per 1,000 pregnant women), hospitalization (by 1.226 per 1,000 pregnant women), mortality (by 0.0036 per 1,000 pregnant women), and saved 0.000305 QALYs versus usual care group. Relative improvement of vaccine uptake by the intervention and number of pregnant women in the healthcare system were two influential factors identified in deterministic sensitivity analysis. The intervention was cost-effective in 99.5% of 10,000 Monte Carlo simulations (at willingness-to-pay threshold 50,000 USD/QALY). A website with vaccine information and interactive social media to promote influenza vaccination for pregnant women appears to reduce direct medical costs and gain QALYs from the perspective of US healthcare providers. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
47. Pre‐vaccination immunotypes reveal weak and robust antibody responders to influenza vaccination.
- Author
-
Cevirgel, Alper, Shetty, Sudarshan A., Vos, Martijn, Nanlohy, Nening M., Beckers, Lisa, Bijvank, Elske, Rots, Nynke, van Beek, Josine, Buisman, Anne‐Marie, and van Baarle, Debbie
- Subjects
- *
INFLUENZA vaccines , *IMMUNOSENESCENCE , *ANTIBODY formation , *OLDER people , *ANTIBODY titer , *IMMUNE system , *KILLER cells - Abstract
Effective vaccine‐induced immune responses are particularly essential in older adults who face an increased risk of immunosenescence. However, the complexity and variability of the human immune system make predicting vaccine responsiveness challenging. To address this knowledge gap, our study aimed to characterize immune profiles that are predictive of vaccine responsiveness using "immunotypes" as an innovative approach. We analyzed an extensive set of innate and adaptive immune cell subsets in the whole blood of 307 individuals (aged 25–92) pre‐ and post‐influenza vaccination which we associated with day 28 hemagglutination inhibition (HI) antibody titers. Building on our previous work that stratified individuals into nine immunotypes based on immune cell subsets, we identified two pre‐vaccination immunotypes associated with weak and one showing robust day 28 antibody response. Notably, the weak responders demonstrated HLA‐DR+ T‐cell signatures, while the robust responders displayed a high naïve‐to‐memory T‐cell ratio and percentage of nonclassical monocytes. These specific signatures deepen our understanding of the relationship between the baseline of the immune system and its functional potential. This approach could enhance our ability to identify individuals at risk of immunosenescence. Our findings highlight the potential of pre‐vaccination immunotypes as an innovative tool for informing personalized vaccination strategies and improving health outcomes, particularly for aging populations. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
48. Exploring strategies to increase college students' motivation to receive their annual influenza vaccine.
- Author
-
Habighorst, Kelsey R., Cillessen, Lisa M., Taylor, Heather M., Reed, Jerilyn J., and Gubbins, Paul O.
- Subjects
- *
HEALTH education , *COLLEGE students , *INFLUENZA vaccines , *PSYCHOLOGY of college students , *IMMUNIZATION , *MOTIVATION (Psychology) , *CROSS-sectional method , *ATTITUDE (Psychology) , *VACCINATION coverage , *HEALTH literacy , *COMPARATIVE studies , *RISK perception , *SEASONAL influenza , *QUESTIONNAIRES , *DESCRIPTIVE statistics , *STUDENT attitudes , *LONGITUDINAL method - Abstract
To evaluate college students' awareness of an educational initiative to increase campus influenza vaccination rates and strategies to improve it. Students attending a large public comprehensive university. An investigator-developed, online survey evaluated awareness of the initiative, the students' perception of incentives, and other motivations to receive seasonal influenza vaccine. The vaccination rate was 43%, despite low awareness of the initiative (28%). Awareness was significantly higher among vaccinated students (p = 0.0013). Having knowledge that appointments to receive vaccine were not needed increased the motivation of vaccinated students more than unvaccinated students (p = 0.0001). Personal influencers increased motivation of vaccinated students only when they were aware of the initiative (p = 0.04). Tangible incentives did not motivate students. Campus vaccination rates increased despite low initiative awareness. Improvements to the initiative should include strategies to increase emphasis on vaccination program conveniences like accessibility and perhaps engage personal influencers more. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
49. Vaccination against influenza viruses reduces infection, not hospitalization or death, from respiratory COVID‐19: A systematic review and meta‐analysis.
- Author
-
Pontiroli, Antonio E., Scovenna, Francesco, Carlini, Valentina, Tagliabue, Elena, Martin‐Delgado, Jimmy, La Sala, Lucia, Tanzi, Elisabetta, and Zanoni, Ivan
- Subjects
SARS-CoV-2 ,MEDICAL personnel ,VIRUS diseases ,INFLUENZA vaccines ,INFLUENZA viruses - Abstract
Severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2) causes COVID‐19 and has brought a huge burden in terms of human lives. Strict social distance and influenza vaccination have been recommended to avoid co‐infections between influenza viruses and SARS‐CoV‐2. Scattered reports suggested a protective effect of influenza vaccine on COVID‐19 development and severity. We analyzed 51 studies on the capacity of influenza vaccination to affect infection with SARS‐CoV‐2, hospitalization, admission to Intensive Care Units (ICU), and mortality. All subjects taken into consideration did not receive any anti‐SARS‐CoV‐2 vaccine, although their status with respect to previous infections with SARS‐CoV‐2 is not known. Comparison between vaccinated and not‐vaccinated subjects for each of the four endpoints was expressed as odds ratio (OR), with 95% confidence intervals (CIs); all analyses were performed by DerSimonian and Laird model, and Hartung‐Knapp model when studies were less than 10. In a total of 61 029 936 subjects from 33 studies, influenza vaccination reduced frequency of SARS‐CoV‐2 infection [OR plus 95% CI = 0.70 (0.65−0.77)]. The effect was significant in all studies together, in health care workers and in the general population; distance from influenza vaccination and the type of vaccine were also of importance. In 98 174 subjects from 11 studies, frequency of ICU admission was reduced with influenza vaccination [OR (95% CI) = 0.71 (0.54−0.94)]; the effect was significant in all studies together, in pregnant women and in hospitalized subjects. In contrast, in 4 737 328 subjects from 14 studies hospitalization was not modified [OR (95% CI) = 1.05 (0.82−1.35)], and in 4 139 660 subjects from 19 studies, mortality was not modified [OR (95% CI) = 0.76 (0.26−2.20)]. Our study emphasizes the importance of influenza vaccination in the protection against SARS‐CoV‐2 infection. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
50. Influenza Vaccination Perceptions and Attitudes among Georgian Dentists: A Cross-Sectional Analysis.
- Author
-
Alkhanishvili, Z., Gogilashvili, K., Gvasalia, N., Samkharadze, S., Lursmanashvili, L., Bakuradze, I., Natsvlishvili, T., and Chkhikvishvili, A.
- Subjects
INFLUENZA vaccines ,VACCINE effectiveness ,VACCINE safety ,MEDICAL misconceptions ,DENTISTS - Abstract
Background: Influenza vaccination remains a cornerstone of public health initiatives aimed at curbing the spread of infectious diseases. Despite the known benefits, vaccine hesitancy persists among healthcare professionals, including dentists, due to concerns about vaccine efficacy and safety. The attitudes of dentists towards influenza vaccination are influenced by a variety of factors, including perceived risks, misconceptions, and personal beliefs. Aim: This study aimed to explore the attitudes and perceptions of Georgian dentists towards influenza vaccination, examining the factors influencing their decision-making and the overall vaccination rates within this group. Methods: A cross-sectional survey was conducted involving 2,900 certified dentists in Georgia. Data were collected on their vaccination status, attitudes towards influenza vaccination, and reasons for acceptance or hesitancy. The survey assessed demographic variables, professional experience, and self-reported knowledge about influenza vaccines. Results: The findings revealed that 16% of the surveyed dentists received an influenza vaccine in the current season. Of the unvaccinated dentists, 30% cited safety concerns, and 21% did not perceive influenza as a significant threat. Experience levels were inversely correlated with vaccine confidence; dentists with less than five years of experience were more likely to get vaccinated compared to their more seasoned counterparts. Additionally, 24% of respondents deemed the vaccine less effective, and only 18% supported mandatory vaccination policies. Geographical trends indicated that the majority of non-vaccinated dentists were from the Imereti and Samegrelo-Zemo Svaneti regions. Conclusions: The study highlights the presence of vaccine hesitancy among dentists in Georgia, with a notable portion exhibiting skepticism towards the flu vaccine's effectiveness and safety. Despite low vaccination rates, the absence of adverse events reported in the past decade provides a basis for addressing safety concerns. Educational interventions tailored to address specific misconceptions and regional disparities are necessary to improve vaccination rates. The research underscores the need for ongoing dialogue and education to bolster confidence in influenza vaccination, thereby enhancing public health outcomes. [ABSTRACT FROM AUTHOR]
- Published
- 2024
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.